Merck, Eisai sign deal to further develop, sell Eisai cancer drug

(Reuters) - Merck& Co and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell Eisai's cancer drug Lenvima, which is already approved in many countries for two uses.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news